Authors:
LIU GQ
EXCOFFON KJDA
BENOIT P
GINZINGER DG
MIAO L
EHRENBORG E
DUVERGER N
DENEFLE PP
HAYDEN MR
LEWIS MES
Citation: Gq. Liu et al., EFFICIENT ADENOVIRUS-MEDIATED ECTOPIC GENE-EXPRESSION OF HUMAN LIPOPROTEIN-LIPASE IN HUMAN HEPATIC (HEPG2) CELLS, Human gene therapy, 8(2), 1997, pp. 205-214
Authors:
LEWIS MES
LIU GQ
GINZINGER DG
BENOIT P
JONES SD
ASHBOURNE KJD
WILSON JE
MCMANUS BM
DUVERGER N
DENEFLE PP
HAYDEN MR
Citation: Mes. Lewis et al., GENE-BASED THERAPEUTIC STRATEGIES FOR HUMAN LIPOPROTEIN-LIPASE (LPL) DEFICIENCY - RATIONALE AND PROSPECTS FOR ALTERATION OF ATHEROGENIC RISK, Transfusion science, 17(1), 1996, pp. 79-87
Authors:
GUERETTE PA
GINZINGER DG
WEBER BHF
GOSLINE JM
Citation: Pa. Guerette et al., SILK PROPERTIES DETERMINED BY GLAND-SPECIFIC EXPRESSION OF A SPIDER FIBROIN GENE FAMILY, Science, 272(5258), 1996, pp. 112-115
Authors:
GINZINGER DG
LEWIS MES
MA YH
JONES BR
LIU GQ
JONES SD
HAYDEN MR
Citation: Dg. Ginzinger et al., A MUTATION IN THE LIPOPROTEIN-LIPASE GENE IS THE MOLECULAR-BASIS OF CHYLOMICRONEMIA IN A COLONY OF DOMESTIC CATS, The Journal of clinical investigation, 97(5), 1996, pp. 1257-1266
Authors:
ZHANG HF
KRAPP A
MA YH
GINZINGER DG
BEISIEGEL U
HAYDEN MR
Citation: Hf. Zhang et al., IN-VITRO MUTAGENESIS STUDIES DEFINES THOSE RESIDUES OF LIPOPROTEIN-LIPASE CRITICAL FOR MEDIATION OF THE BINDING OF LIPOPROTEINS TO THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP), Circulation, 90(4), 1994, pp. 289-289
Authors:
ZHANG HF
KRAPP A
MA YH
GINZINGER DG
BEISIEGEL U
HAYDEN MR
Citation: Hf. Zhang et al., IN-VITRO MUTAGENESIS STUDIES DEFINES THOSE RESIDUES OF LIPOPROTEIN-LIPASE CRITICAL FOR MEDIATION OF THE BINDING OF LIPOPROTEINS TO THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP), Circulation, 90(4), 1994, pp. 289-289
Authors:
GINZINGER DG
MA YH
LIU MS
HARVEYCLARKE C
BRUNZELL JD
HAYDEN MR
Citation: Dg. Ginzinger et al., MOLECULAR CHARACTERIZATION OF LIPOPROTEIN-LIPASE DEFICIENCY IN THE CAT - AN ANIMAL-MODEL FOR HUMAN LIPOPROTEIN-LIPASE DEFICIENCY, Circulation, 88(4), 1993, pp. 268-268